Given its central role in fatty acid metabolism, CPT I is a potential therapeutic target for conditions like obesity, type 2 diabetes, and cardiovascular diseases. Modulating CPT I activity can influence the rate of fatty acid oxidation, offering a strategy to manage metabolic imbalances. Histological studies are essential in evaluating the effects of potential CPT I modulators on tissue metabolism and overall energy homeostasis.
